Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06378190
Title Treatment of Relapsed or Refractory B-cell Lymphoma With Chimeric Antigen Receptor (CAR) T-cell Therapy Produced by a New Technology (TranspoCART19)
Acronym TranspoCART19
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Instituto de Investigacion Biomedica de Salamanca
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP


No variant requirements are available.